目的：探讨雷贝拉唑、铝碳酸镁以及两药联合对胆囊切除后伴有胆汁反流胃炎的临床治疗疗效。方法：选取我院在2011年01月到2013年03月收治的90例胆囊切除后伴有胆汁反流胃炎患者随即分A组、B组、C组，A组患者给予单独雷贝拉唑治疗，B组患者给予单独铝碳酸镁治疗，C组患者给予雷贝拉唑联合铝碳酸镁治疗。结果：A 组、B 组患者和 C 组患者在临床疗效总有效率上存在显著差异性（P<0.05）。结论：雷贝拉唑联合铝碳酸镁应用于治疗胆囊切除后伴有胆汁反流胃炎疗效显著。
objective:to study the rabeprazole azole, aluminum and magnesium carbonate, and the combination of the two drugs after cystic resection associated with the clinical curative effect of bile reflux gastritis. Selection methods:our hospital in January 2011 to March 2013, 90 cases with bile reflux gastritis patients immediately after cystic resection points in group A, group B and group C, group A patients to give separate rabeprazole azole treatment, B group patients give hydrotalcite treatment alone, group C with ray united aluminum magnesium carbonate (.) treatment Results:group A and group B and group C in patients in the clinical curative effect on the total effective rate have significant difference (P < 0.05). Conclusion rabeprazole azole united aluminum magnesium carbonate used in treatment after cystic resection with bile reflux gastritis, curative effect is distinct.
NETL
NSTL
万方数据
